AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
251280 | KO
Overview
Corporate Details
- ISIN(s):
- KR7251280004
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 테크노3로 65, 대전광역시
- Website:
- https://angiolab.co.kr/
Description
AngioLab, Inc. is a biotechnology company specializing in the discovery and development of angiogenesis inhibitors. The company develops pharmaceuticals and health functional foods to treat diseases associated with the abnormal growth of blood vessels. Its pipeline includes drug candidates targeting conditions such as age-related macular degeneration (AMD), with some candidates having undergone Phase II clinical trials. AngioLab has also developed Ob-X, a functional food ingredient based on its anti-angiogenic research platform.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-09-18 00:00 |
주권매매거래정지해제(회사합병 철회)
|
Korean | 4.4 KB | ||
| 2020-06-29 00:00 |
주요사항보고서(회사합병결정)
|
Korean | 42.9 KB | ||
| 2020-06-29 00:00 |
주권매매거래정지
|
Korean | 4.9 KB | ||
| 2020-06-23 00:00 |
기업설명회(IR)개최결과
|
Korean | 7.1 KB | ||
| 2020-06-18 00:00 |
기업설명회(IR)개최
|
Korean | 7.4 KB | ||
| 2020-06-08 00:00 |
특허권취득(자율공시)
|
Korean | 6.1 KB | ||
| 2020-03-30 00:00 |
사업보고서 (2019.12)
|
Korean | 954.3 KB | ||
| 2020-03-26 00:00 |
정기주주총회결과
|
Korean | 21.9 KB | ||
| 2020-03-26 00:00 |
주식매수선택권부여에관한신고
|
Korean | 16.4 KB | ||
| 2020-03-18 00:00 |
감사보고서제출
|
Korean | 10.2 KB | ||
| 2020-03-04 00:00 |
주주총회소집공고
|
Korean | 219.8 KB | ||
| 2020-02-28 00:00 |
주주총회소집결의
|
Korean | 11.8 KB | ||
| 2020-02-28 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.2 KB | ||
| 2020-02-20 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 136.9 KB | ||
| 2020-02-13 00:00 |
주식매수선택권부여에관한신고
|
Korean | 24.7 KB |
Automate Your Workflow. Get a real-time feed of all AngioLab, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AngioLab, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AngioLab, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
